RT @PerryVreug87: ##Filgotinib (JAK1) and Ulcerative Colitis. "Therefore, it has been hypothesized that a more selective JAK inhibition t…
RT @PerryVreug87: ##Filgotinib (JAK1) and Ulcerative Colitis. "Therefore, it has been hypothesized that a more selective JAK inhibition t…
RT @PerryVreug87: ##Filgotinib (JAK1) and Ulcerative Colitis. "Therefore, it has been hypothesized that a more selective JAK inhibition t…
RT @PerryVreug87: ##Filgotinib (JAK1) and Ulcerative Colitis. "Therefore, it has been hypothesized that a more selective JAK inhibition t…
RT @PerryVreug87: ##Filgotinib (JAK1) and Ulcerative Colitis. "Therefore, it has been hypothesized that a more selective JAK inhibition t…
@GalapagosGlobal
RT @PerryVreug87: ##Filgotinib (JAK1) and Ulcerative Colitis. "Therefore, it has been hypothesized that a more selective JAK inhibition t…
##Filgotinib (JAK1) and Ulcerative Colitis. "Therefore, it has been hypothesized that a more selective JAK inhibition toward a JAK1 preferential inhibition (..) could improve safety and efficacy in IBD".. #UC #IBD $GLPG @GalapagosGlobal @GileadSciences